Trial Outcomes & Findings for A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration (NCT NCT01438541)

NCT ID: NCT01438541

Last Updated: 2016-10-14

Results Overview

Total improvement of erythema

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

29 participants

Primary outcome timeframe

14 days

Results posted on

2016-10-14

Participant Flow

The recruitment period was from 03 October 2011-21 February 2012. The study was conducted at three wound care units in United Kingdom.

There was no wash-out or run-in phase included in the study.

Participant milestones

Participant milestones
Measure
Window
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Overall Study
STARTED
29
Overall Study
COMPLETED
22
Overall Study
NOT COMPLETED
7

Reasons for withdrawal

Reasons for withdrawal
Measure
Window
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Overall Study
Physician Decision
1
Overall Study
Withdrawal by Subject
1
Overall Study
discharge from the hospital
5

Baseline Characteristics

A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Window
n=29 Participants
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Age, Continuous
68.6 years
STANDARD_DEVIATION 16.9 • n=99 Participants
Sex: Female, Male
Female
20 Participants
n=99 Participants
Sex: Female, Male
Male
9 Participants
n=99 Participants
Region of Enrollment
United Kingdom
29 participants
n=99 Participants

PRIMARY outcome

Timeframe: 14 days

Population: Vulnerable subjects with high risk of skin breakdown.

Total improvement of erythema

Outcome measures

Outcome measures
Measure
Window
n=29 Participants
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Erythema ( No/Yes)
Erytema Baseline Yes
24 participants
Erythema ( No/Yes)
Erythema Last visit No
16 participants
Erythema ( No/Yes)
Erytehma Last visit Yes
13 participants
Erythema ( No/Yes)
Erytehma Baseline No
5 participants

SECONDARY outcome

Timeframe: 14 days

Investigator and Nurses evaluate the overall Experience of using of the dressing rated on a scale from Very Poor, Poor,Good, Very Good, Excellent, Not measured

Outcome measures

Outcome measures
Measure
Window
n=29 Participants
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Overall Experience of Use of the Dressing
Very Poor
1 participants
Overall Experience of Use of the Dressing
Poor
10 participants
Overall Experience of Use of the Dressing
Good
15 participants
Overall Experience of Use of the Dressing
Very Good
0 participants
Overall Experience of Use of the Dressing
Excellent
1 participants
Overall Experience of Use of the Dressing
Not measured
2 participants

SECONDARY outcome

Timeframe: 14 days

Investigator and Nurses evaluated the shape of the dressing rated on a scale from Very Poor, Poor,Good, Very Good, Excellent

Outcome measures

Outcome measures
Measure
Window
n=29 Participants
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Evaluate the Dressing Shape
Very Poor
0 participants
Evaluate the Dressing Shape
Poor
4 participants
Evaluate the Dressing Shape
Good
22 participants
Evaluate the Dressing Shape
Very Good
1 participants
Evaluate the Dressing Shape
Excellent
2 participants

Adverse Events

Window

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Window
n=29 participants at risk
WindowTM is a protective layer that may reduce the shear and friction on the skin and may help to prevent skin breakdown.
Skin and subcutaneous tissue disorders
Ruptured blister - broken skin
3.4%
1/29 • Number of events 1 • Adverse Events were collected from baseline to termination (14days)
Skin and subcutaneous tissue disorders
Recurrence of ruptured blister in different
3.4%
1/29 • Number of events 1 • Adverse Events were collected from baseline to termination (14days)
Skin and subcutaneous tissue disorders
Grade 2 area to L buttock 2mm x 2 mm
3.4%
1/29 • Number of events 1 • Adverse Events were collected from baseline to termination (14days)

Additional Information

Tina Kjellén

Molnlycke Health Care AB

Phone: +46317223098

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place